Multi-level Functional Connectivity Fusion Classification Framework for Brain Disease Diagnosis

Automated Diagnosis of Major Depressive Disorder With Multi-Modal MRIs Based on Contrastive Learning: A Few-Shot Study

Depression ranks among the most prevalent mood-related psychiatric disorders. Existing clinical diagnostic approaches relying on scale interviews are susceptible to individual and environmental variations. In contrast, the integration of neuroimaging techniques and computer science has provided compelling evidence for the quantitative assessment of major depressive disorder (MDD). However, one of the major challenges in computer-aided diagnosis of MDD is to automatically and effectively mine the complementary cross-modal information from limited datasets. In this study, we proposed a few-shot learning framework that integrates multi-modal MRI data based on contrastive learning. In the upstream task, it is designed to extract knowledge from heterogeneous data. Subsequently, the downstream task is dedicated to transferring the acquired knowledge to the target dataset, where a hierarchical fusion paradigm is also designed to integrate features across inter- and intra-modalities. Lastly, the proposed model was evaluated on a set of multi-modal clinical data, achieving average scores of 73.52% and 73.09% for accuracy and AUC, respectively. Our findings also reveal that the brain regions within the default mode network and cerebellum play a crucial role in the diagnosis, which provides further direction in exploring reproducible biomarkers for MDD diagnosis.

Effective hyper-connectivity network construction and learning: Application to major depressive disorder identification

Functional connectivity (FC) derived from resting-state fMRI (rs-fMRI) is a primary approach for identifying brain diseases, but it is limited to capturing the pairwise correlation between regions-of-interest (ROIs) in the brain. Thus, hyper-connectivity which describes the higher-order relationship among multiple ROIs is receiving increasing attention. However, most hyper-connectivity methods overlook the directionality of connections. The direction of information flow constitutes a pivotal factor in shaping brain activity and cognitive processes. Neglecting this directional aspect can lead to an incomplete understanding of high-order interactions within the brain. To this end, we propose a novel effective hyper-connectivity (EHC) network that integrates direction detection and hyper-connectivity modeling. It characterizes the high-order directional information flow among multiple ROIs, providing a more comprehensive understanding of brain activity. Then, we develop a directed hypergraph convolutional network (DHGCN) to acquire deep representations from EHC network and functional indicators of ROIs. In contrast to conventional hypergraph convolutional networks designed for undirected hypergraphs, DHGCN is specifically tailored to handle directed hypergraph data structures. Moreover, unlike existing methods that primarily focus on fMRI time series, our proposed DHGCN model also incorporates multiple functional indicators, providing a robust framework for feature learning. Finally, deep representations generated via DHGCN, combined with demographic factors, are used for major depressive disorder (MDD) identification. Experimental results demonstrate that the proposed framework outperforms both FC and undirected hyper-connectivity models, as well as surpassing other state-of-the-art methods. The identification of EHC abnormalities through our framework can enhance the analysis of brain function in individuals with MDD.

Multi-feature concatenation and multi-classifier stacking: An interpretable and generalizable machine learning method for MDD discrimination with rsfMRI

Major depressive disorder (MDD) is a serious and heterogeneous psychiatric disorder that needs accurate diagnosis. Resting-state functional MRI (rsfMRI), which captures multiple perspectives on brain structure, function, and connectivity, is increasingly applied in the diagnosis and pathological research of MDD. Different machine learning algorithms are then developed to exploit the rich information in rsfMRI and discriminate MDD patients from normal controls. Despite recent advances reported, the MDD discrimination accuracy has room for further improvement. The generalizability and interpretability of the discrimination method are not sufficiently addressed either. Here, we propose a machine learning method (MFMC) for MDD discrimination by concatenating multiple features and stacking multiple classifiers. MFMC is tested on the REST-meta-MDD data set that contains 2428 subjects collected from 25 different sites. MFMC yields 96.9% MDD discrimination accuracy, demonstrating a significant improvement over existing methods. In addition, the generalizability of MFMC is validated by the good performance when the training and testing subjects are from independent sites. The use of XGBoost as the meta classifier allows us to probe the decision process of MFMC. We identify 13 feature values related to 9 brain regions including the posterior cingulate gyrus, superior frontal gyrus orbital part, and angular gyrus, which contribute most to the classification and also demonstrate significant differences at the group level. The use of these 13 feature values alone can reach 87% of MFMC's full performance when taking all feature values. These features may serve as clinically useful diagnostic and prognostic biomarkers for MDD in the future.

An attention-based multi-modal MRI fusion model for major depressive disorder diagnosis

Objective.Major depressive disorder (MDD) is one of the biggest threats to human mental health. MDD is characterized by aberrant changes in both structure and function of the brain. Although recent studies have developed some deep learning models based on multi-modal magnetic resonance imaging (MRI) for MDD diagnosis, the latent associations between deep features derived from different modalities were largely unexplored by previous studies, which we hypothesized may have potential benefits in improving the diagnostic accuracy of MDD.Approach.In this study, we proposed a novel deep learning model that fused both structural MRI (sMRI) and resting-state MRI (rs-fMRI) data to enhance the diagnosis of MDD by capturing the interactions between deep features extracted from different modalities. Specifically, we first employed a brain function encoder (BFE) and a brain structure encoder (BSE) to extract the deep features from fMRI and sMRI, respectively. Then, we designed a function and structure co-attention fusion (FSCF) module that captured inter-modal interactions and adaptively fused multi-modal deep features for MDD diagnosis.Main results.This model was evaluated on a large cohort and achieved a high classification accuracy of 75.2% for MDD diagnosis. Moreover, the attention distribution of the FSCF module assigned higher attention weights to structural features than functional features for diagnosing MDD.Significance.The high classification accuracy highlights the effectiveness and potential clinical of the proposed model.

Fusing Multiview Functional Brain Networks by Joint Embedding for Brain Disease Identification

Background: Functional brain networks (FBNs) derived from resting-state functional MRI (rs-fMRI) have shown great potential in identifying brain disorders, such as autistic spectrum disorder (ASD). Therefore, many FBN estimation methods have been proposed in recent years. Most existing methods only model the functional connections between brain regions of interest (ROIs) from a single view (e.g., by estimating FBNs through a specific strategy), failing to capture the complex interactions among ROIs in the brain. Methods: To address this problem, we propose fusion of multiview FBNs through joint embedding, which can make full use of the common information of multiview FBNs estimated by different strategies. More specifically, we first stack the adjacency matrices of FBNs estimated by different methods into a tensor and use tensor factorization to learn the joint embedding (i.e., a common factor of all FBNs) for each ROI. Then, we use Pearson's correlation to calculate the connections between each embedded ROI in order to reconstruct a new FBN. Results: Experimental results obtained on the public ABIDE dataset with rs-fMRI data reveal that our method is superior to several state-of-the-art methods in automated ASD diagnosis. Moreover, by exploring FBN "features" that contributed most to ASD identification, we discovered potential biomarkers for ASD diagnosis. The proposed framework achieves an accuracy of 74.46%, which is generally better than the compared individual FBN methods. In addition, our method achieves the best performance compared to other multinetwork methods, i.e., an accuracy improvement of at least 2.72%. Conclusions: We present a multiview FBN fusion strategy through joint embedding for fMRI-based ASD identification. The proposed fusion method has an elegant theoretical explanation from the perspective of eigenvector centrality.

The classification of brain network for major depressive disorder patients based on deep graph convolutional neural network

Introduction

The early diagnosis of major depressive disorder (MDD) is very important for patients that suffer from severe and irreversible consequences of depression. It has been indicated that functional connectivity (FC) analysis based on functional magnetic resonance imaging (fMRI) data can provide valuable biomarkers for clinical diagnosis. However, previous studies mainly focus on brain disease classification in small sample sizes, which may lead to dramatic divergences in classification accuracy.

Methods

This paper attempts to address this limitation by applying the deep graph convolutional neural network (DGCNN) method on a large multi-site MDD dataset. The resting-state fMRI data are acquired from 830 MDD patients and 771 normal controls (NC) shared by the REST-meta-MDD consortium.

Results

The DGCNN model trained with the binary network after thresholding, identified MDD patients from normal controls and achieved an accuracy of 72.1% with 10-fold cross-validation, which is 12.4%, 9.8%, and 7.6% higher than SVM, RF, and GCN, respectively. Moreover, the process of dataset reading and model training is faster. Therefore, it demonstrates the advantages of the DGCNN model with low time complexity and sound classification performance.

Discussion

Based on a large, multi-site dataset from MDD patients, the results expressed that DGCNN is not an extremely accurate method for MDD diagnosis. However, there is an improvement over previous methods with our goal of better understanding brain function and ultimately providing a biomarker or diagnostic capability for MDD diagnosis.